Arrowhead Pharmaceuticals, Inc. ( ARWR) Reviews Meantime Arise From Excessive Weight Candidates and Breakthroughs in Therapy Comes Close To January 6, 2026 11:30 AM EST
Business Individuals
Vincent Anzalone – Head of Capitalist Relations & & VP
James Hamilton – Principal Medical Police Officer and Head of R&D
Dr. Christopher Anzalone – Chairman, CHIEF EXECUTIVE OFFICER & & Head Of State
Teleconference Individuals
Carel le Roux
Prakhar Agrawal – Cantor Fitzgerald & & Co., Study Department
Jason Gerberry – BofA Stocks, Study Department
Luca Issi – RBC Funding Markets, Study Department
Madison Wynne El-Saadi – B. Riley Stocks, Inc., Study Department
Peanut Foroohar – Leerink Allies LLC, Study Department
Maurice Raycroft – Jefferies LLC, Study Department
Michael Ulz – Morgan Stanley, Study Department
Patrick Trucchio – H.C. Wainwright & & Carbon Monoxide, LLC, Study Department
Andrea Tan – Goldman Sachs Team, Inc., Study Department
Joseph Thome – TD Cowen, Study Department
William Pickering – Bernstein Institutional Providers LLC, Study Department
Discussion
Driver
Greetings, and welcome to the Arrowhead Pharmaceuticals’ Online KOL occasion.[Operator Instructions] As a suggestion, this phone call is being taped, and a replay will certainly be readily available on the Arrowhead internet site adhering to the occasion.
I’ll currently transform the phone call over to Vincent Anzalone, Arrowhead’s Vice Head of state of Financing and Capitalist Relations. Please proceed, Vince.
Vincent Anzalone
Head of Capitalist Relations & & VP
Many thanks a lot, Wilson, and many thanks, everyone, for joining us today. We are delighted to discuss our very first acting arise from our 2 excessive weight prospects, ARO-INHBE and ARO-ALK7. Journalism launch headed out today. So I would certainly such as for every one of you to describe that. Furthermore, we will certainly be making progressive declarations today. So please describe the threat consider our SEC filings.
So what we’re attempting to complete today is we have an exterior excessive weight and metabolic condition professional, Dr. Carel Le Roux, that will certainly join us. He’s mosting likely to discuss what we see and what he